RxFinder.ai

Glimepiride

Sulfonylurea

NADAC/unit $0.0237
No Shortage Tier 1: 228.6% PA Req: 0.9% 8 Manufacturers 28 ANDAs

Glimepiride stimulates insulin release from the pancreas to lower blood sugar.

Market Intelligence

2024-02-14 Class III Recall: Dr. Reddy's Laboratories, Inc.
2024-02-14 Class III Recall: Dr. Reddy's Laboratories, Inc.
2023-05-03 Class II Recall: Northwind Pharmaceuticals LLC
2023-05-03 Class II Recall: Northwind Pharmaceuticals LLC
2023-03-08 Class II Recall: Accord Healthcare, Inc.

Generic Manufacturers

ACCORD HEALTHCARE INCAUROBINDO PHARMA LTDCARLSBAD TECHNOLOGY INCCHARTWELL MOLECULAR HOLDINGS LLCDR REDDYS LABORATORIES LTDMICRO LABS LTDPRINSTON PHARMACEUTICAL INCREGCON HOLDINGS LLC

Explore in the Ecosystem

rxsaver.aiCompare prices for Glimepiridedrfinder.aiFind doctors who prescribe Glimepiriderxnews.aiLatest news about Glimepiride

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.